Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 19

1.

Erratum to: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion.

Working Group Nientemale DEI, Vellucci R, Fanelli G, Pannuti R, Peruselli C, Adamo S, Alongi G, Amato F, Consoletti L, Lamarca L, Liguori S, Presti CL, Maione A, Mameli S, Marinangeli F, Marulli S, Minotti V, Miotti D, Montanari L, Moruzzi G, Palermo S, Parolini M, Poli P, Tirelli W, Valle A, Romualdi P.

Drugs. 2016 Apr;76(6):731-732. No abstract available.

PMID:
27055526
2.

What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion.

Working Group Nientemale DEI, Vellucci R, Fanelli G, Pannuti R, Peruselli C, Adamo S, Alongi G, Amato F, Consoletti L, Lamarca L, Liguori S, Lo Presti C, Maione A, Mameli S, Marinangeli F, Marulli S, Minotti V, Miotti D, Montanari L, Moruzzi G, Palermo S, Parolini M, Poli P, Tirelli W, Valle A, Romualdi P.

Drugs. 2016 Mar;76(3):315-30. doi: 10.1007/s40265-015-0519-2. Erratum in: Drugs. 2016 Apr;76(6):731-2.

3.

Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study.

Mercadante S, Tirelli W, David F, Arcara C, Fulfaro F, Casuccio A, Gebbia V.

Clin J Pain. 2010 Nov-Dec;26(9):794-7.

PMID:
20973155
4.

When the progression of disease lowers opioid requirement in cancer patients.

Mercadante S, Ferrera P, Di Emidio L, Arcuri E, Tirelli W.

Clin J Pain. 2010 Jan;26(1):56-7. doi: 10.1097/AJP.0b013e3181bff90d.

PMID:
20026954
5.

Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study.

Mercadante S, Porzio G, Ferrera P, Aielli F, Verna L, Tirelli W, Villari P, Casuccio A.

Clin Ther. 2009 Oct;31(10):2134-8. doi: 10.1016/j.clinthera.2009.10.013.

PMID:
19922884
6.

Equipotent doses to switch from high doses of opioids to transdermal buprenorphine.

Mercadante S, Casuccio A, Tirelli W, Giarratano A.

Support Care Cancer. 2009 Jun;17(6):715-8. doi: 10.1007/s00520-008-0546-6. Epub 2008 Dec 23.

PMID:
19104845
7.

Low morphine doses in opioid-naive cancer patients with pain.

Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Ficorella C, Verna L, Tirelli W, Villari P, Arcuri E.

J Pain Symptom Manage. 2006 Mar;31(3):242-7.

PMID:
16563318
8.

Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain.

Mercadante S, Arcuri E, Fusco F, Tirelli W, Villari P, Bussolino C, Campa T, De Conno F, Ripamonti C.

Support Care Cancer. 2005 Sep;13(9):702-7. Epub 2005 Jan 12.

PMID:
15645186
9.

Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices.

Laurenzi L, Natoli S, Benedetti C, Marcelli ME, Tirelli W, DiEmidio L, Arcuri E.

Support Care Cancer. 2004 Nov;12(11):805-9.

PMID:
15372220
10.

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group.

Caraceni A, Zecca E, Bonezzi C, Arcuri E, Yaya Tur R, Maltoni M, Visentin M, Gorni G, Martini C, Tirelli W, Barbieri M, De Conno F.

J Clin Oncol. 2004 Jul 15;22(14):2909-17.

11.

Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.

Mercadante S, Arcuri E, Tirelli W, Villari P, Casuccio A.

Tumori. 2002 May-Jun;88(3):239-42.

PMID:
12195763
12.

Preliminary in vivo experimental evidence on intratumoral morphine uptake. Possible clinical implications in cancer pain and opioid responsiveness.

Arcuri E, Ginobbi P, Tirelli W, Froldi R, Citro G, Santoni A.

J Pain Symptom Manage. 2002 Jul;24(1):1-3. No abstract available.

PMID:
12183084
13.

[Opioids. Pharmacology, clinic, prospectives for an extensive use].

Ginobbi P, Tirelli W, D'Angiolino G, Ciocca F, Centulio F, Pelagalli L, Marcelli ME, Arcuri E.

Recenti Prog Med. 2000 Dec;91(12):621-7. Italian. No abstract available.

PMID:
11194479
14.

Opioid nonresponsiveness in cancer pain can be reversible. A serendipitous conclusion of a refrospective analysis.

Arcuri E, Mercadante S, Laurenzi L, Natoli S, Centulio F, Fusco G, Ginobbi P, Tirelli W.

J Pain Symptom Manage. 2000 Dec;20(6):393-4. No abstract available.

PMID:
11131254
15.
16.

[The development of the first hospice organization in central Italy one year after its starting to operate].

Tirelli W, Ginobbi P, Penco I, Caratelli A, Arcuri E.

Minerva Med. 1999 Jul-Aug;90(7-8):245-6. Italian. No abstract available.

PMID:
10719429
17.

Psychological and symptom distress in terminal cancer patients with met and unmet needs.

Morasso G, Capelli M, Viterbori P, Di Leo S, Alberisio A, Costantini M, Fiore M, Saccani D, Zeitler G, Verzolatto N, Tirelli W, Lazzari L, Partinico M, Borzoni G, Savian C, Obertino E, Zotti P, Ivaldi GP, Henriquet F.

J Pain Symptom Manage. 1999 Jun;17(6):402-9.

PMID:
10388245
18.

[Transdermal route as an alternative to oral administration of opioids in cancer pain].

Burza M, Ginobbi P, Fusco G, Laurenzi L, Tirelli W, Arcuri E.

Clin Ter. 1998 Jul-Aug;149(4):277-80. Italian.

PMID:
9866889
19.

Complications with fully implantable venous access systems in oncologic patients.

Laurenzi L, Fimiani C, Faglieri N, Natoli S, Milasi G, Tirelli W, Arcuri E.

Tumori. 1996 May-Jun;82(3):232-6.

PMID:
8693600
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk